Natixis’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
+2,589
New +$219K ﹤0.01% 930
2024
Q4
– Sell
-2,360
Closed -$193K – 1114
2024
Q3
$193K Sell
2,360
-583
-20% -$45K ﹤0.01% 710
2024
Q2
$254K Buy
+2,943
New +$238K ﹤0.01% 675
2024
Q1
– Sell
-71,695
Closed -$4.75M – 1107
2023
Q4
$4.75M Buy
+71,695
New +$4.97M 0.03% 302
2021
Q1
– Sell
-10,022
Closed -$699K – 1119
2020
Q4
$699K Buy
+10,022
New +$623K ﹤0.01% 858
2017
Q4
– Sell
-7,395
Closed -$374K – 987
2017
Q3
$374K Buy
+7,395
New +$344K ﹤0.01% 805
2017
Q2
– Sell
-4,800
Closed -$204K – 892
2017
Q1
$204K Buy
+4,800
New +$212K ﹤0.01% 886

Other funds holding HQY

Natixis's HQY Position: Q2 2026 in Review

Natixis opened a new position in HealthEquity (HQY) in Q2 2026: 2,589 shares worth $234K. The stake represents ﹤0.01% of the portfolio and ranks #930 among its holdings. This is a return to the name: Natixis previously reported a position in HQY as recently as Q3 2024.

Natixis first reported a position in HQY in Q1 2017 and has held it in 7 quarters since. The position peaked at $4.75M in Q4 2023. 501 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Natixis held 2,589 shares of HealthEquity worth $234K as of Q2 2026.
  • HealthEquity was a new Natixis position in Q2 2026.
  • HealthEquity made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #930 holding.
  • Natixis first reported a position in HealthEquity in Q1 2017 and has held it in 7 quarters since.
  • Natixis's HealthEquity position peaked at $4.75M in Q4 2023.
  • 501 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.